经颈静脉肝内门体分流术后发作性显性肝性脑病不增加肝硬化患者死亡率
多中心非劣效性观察研究纳入三个意大利中心614例接受经颈静脉肝内门体分流术(TIPS)的肝硬化患者,中位随访30个月,293例发生至少一次显性肝性脑病(OHE)。有无术后OHE者30个月死亡率差值为0.03(95%CI -0.042至0.102),多变量分析显示年龄与MELD评分而非术后OHE与更高死亡率相关,结论为发作性OHE与死亡率无关。
要点
- TIPS术后发作性OHE不增加肝硬化患者30个月死亡率。
- 年龄(亚分布风险比1.04)与MELD评分(亚分布风险比1.09)与更高死亡率相关。
- 死亡组中TIPS后持续性OHE的比例显著更高。
核心结论
- TIPS术后发作性OHE与接受TIPS患者的死亡率无关,无论适应证如何。
研究设计与样本
- 多中心、非劣效性、观察性研究,分析三个意大利中心614例接受TIPS的患者,非劣效性界限设为0.12。
主要发现
- 中位随访30个月(IQR 12-30),293例发生至少一次OHE,其中27例(9.2%)出现复发/持续性OHE。
- OHE组较无OHE组年龄更大(64[57-71]岁 vs 59[50-67]岁,p<0.001),白蛋白更低(3.1[2.8-3.5] g/dl vs 3.25[2.9-3.6] g/dl,p=0.023),TIPS前OHE患病率更高(15.4% vs 9.0%,p=0.023)。
- 有无TIPS术后OHE患者30个月死亡率差值为0.03(95%CI -0.042至0.102)。
- 多变量分析显示年龄(亚分布风险比1.04,95%CI 1.02-1.05,p<0.001)和MELD评分(亚分布风险比1.09,95%CI 1.05-1.13,p<0.001)与更高死亡率相关,而TIPS术后OHE无此关联。
- 死亡组中TIPS后持续性OHE的比例显著更高,倾向性评分匹配后结果稳健性增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Overt hepatic encephalopathy (OHE) is a major complication of transjugular intrahepatic portosystemic shunt (TIPS) placement, given its high incidence and possibility of refractoriness to medical treatment. Nevertheless, the impact of post-TIPS OHE on mortality has not been investigated in a large population. METHODS: We designed a multicenter, non-inferiority, observational study to evaluate the mortality rate at 30 months in patients with and without OHE after TIPS. We analyzed a database of 614 patients who underwent TIPS in three Italian centers and estimated the cumulative incidence of OHE and mortality with competitive risk analyses, setting the non-inferiority limit at 0.12. RESULTS: During a median follow-up of 30 months (IQR 12-30), 293 patients developed at least one episode of OHE. Twenty-seven (9.2%) of them experienced recurrent/persistent OHE. Patients with OHE were older (64 [57-71] vs. 59 [50-67] years, p <0.001), had lower albumin (3.1 [2.8-3.5] vs. 3.25 [2.9-3.6] g/dl, p = 0.023), and had a higher prevalence of pre-TIPS OHE (15.4% vs. 9.0%, p = 0.023). Child-Pugh and MELD scores were similar. The 30-month difference in mortality between patients with and without post-TIPS OHE was 0.03 (95% CI -0.042 to 0.102). Multivariable analysis showed that age (subdistribution hazard ratio 1.04, 95% CI 1.02-1.05, p <0.001) and MELD score (subdistribution hazard ratio 1.09, 95% CI 1.05-1.13, p <0.001), but not post-TIPS OHE, were associated with a higher mortality rate. Similar results were obtained when patients undergoing TIPS for variceal re-bleeding prophylaxis (n = 356) or refractory ascites (n = 258) were analyzed separately. The proportion of patients with persistent OHE after TIPS was significantly higher in the group of patients who died. The robustness of these results was increased following propensity score matching. CONCLUSION: Episodic OHE after TIPS is not associated with mortality in patients undergoing TIPS, regardless of the indication. IMPACT AND IMPLICATIONS: Overt hepatic encephalopathy (OHE) is a common complication in patients with advanced liver disease and it is particularly frequent following transjugular intrahepatic portosystemic shunt (TIPS) placement. In patients with cirrhosis outside the setting of TIPS, the development of OHE negatively impacts survival, regardless of the severity of cirrhosis or the presence of acute-on-chronic liver failure. In this multicenter, non-inferiority, observational study we demonstrated that post-TIPS OHE does not increase the risk of mortality in patients undergoing TIPS, irrespective of the indication. This finding alleviates concerns regarding the weight of this complication after TIPS. Intensive research to improve patient selection and risk stratification remains crucial to enhance the quality of life of patients and caregivers and to avoid undermining the positive effects of TIPS on survival.
引用
- Nardelli S, Riggio O, Marra F, et al. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis. J Hepatol. 2023. PMID: 38097113. doi:10.1016/j.jhep.2023.11.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。